MOUNJARO 2.5 mg/dose KwikPen, solution for injection in a pre-filled pen pen, 2.4 ml
Brand page: Mounjaro (tirzepatide) — all forms and strengths in France
Active ingredients: Tirzepatide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 2.4 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOUNJARO 2,5 mg/dose KwikPen solution injectable en stylo pré-rempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche en verre multidose(s) de 2,4 mL dans un stylo pré-rempli
- Marketing authorisation holder
- ELI LILLY NEDERLAND BV (PAY-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60830260CIP73029290CIP133400930292907Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TIRZÉPATIDEsolution | 2,5 mg · une dose de 0,6 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.